10x Genomics Ignites: TXG Explodes 9.56% to Shatter 52-Week Highs in Biotech Surge

Summary
• 10x Genomics (TXG) surges 9.56% intraday, closing near $49.96 and reclaiming its 52-week peak of $50.47.

• Q2 earnings demonstrated robust revenue beats, fueling aggressive institutional and retail buying pressure.

• Technical indicators show a decisive breakout above key moving averages, with the RSI cooling from extreme levels.

• Options activity reveals heavy volume in near-term calls, signaling strong bullish conviction among traders.

The market took notice of 10x Genomics' renewed momentum today, as the stock pierced through resistance levels to test its all-time highs. Driven by a combination of solid fundamental performance and technical breakout signals, TXG has emerged as a standout performer in the biotechnology sector, drawing significant capital inflows.
Q2 Earnings Beat Fuels Breakout Momentum
The primary catalyst for today's 9.56% surge is the market's reaction to 10x Genomics' Q2 earnings report, which significantly beat revenue estimates. This fundamental validation has shifted sentiment, prompting traders to bid the price up from an open of $44.992 to an intraday high of $50.47. The strong performance suggests that the company's growth trajectory is intact, encouraging both short-covering and new long positions to enter the market.

Biotechnology Sector Divergence: TXG Outperforms Peer ILMN
While 10x Genomics is trading within the Biotechnology sector, today's price action highlights a stark divergence from sector leader Illumina (ILMN), which declined by 2.21%. This contrast indicates that TXG's rally is company-specific, driven by its unique earnings strength rather than broad sector rotation. Investors are clearly favoring TXG's idiosyncratic growth story over the broader sector headwinds affecting peers like Illumina.

Technical Breakout Strategy: Leveraging Call Options on Momentum
The technical landscape for 10x Genomics supports a bullish stance following the breakout. Key indicators include:
• 30-day Moving Average: 43.48 (Price is significantly above, indicating strong short-term bullish momentum)
• 100-day Moving Average: 30.11 (Price is well above, confirming the long-term uptrend)
• 200-day Moving Average: 24.06 (Price is massively above, showing long-term structural strength)
• RSI: 55.08 (Neutral to slightly bullish, suggesting room for further upside without being overbought)
• MACD Histogram: -0.54 (Negative but converging, hinting at potential bullish crossover)

The stock has decisively broken above its 30-day support/resistance zone of $46.96–$47.23, opening the path toward new highs. With no leveraged ETF data available, the focus shifts to options for leveraged exposure. The current RSI of 55.08 suggests the stock is not yet overextended, allowing for continued upside potential. Traders should look for support at the previous resistance-turned-support level around $47.23.

Based on the provided options chain, here are two high-potential picks for aggressive bullish exposure:

Contract 1: TXG20260821C50
• Code: TXG20260821C50
• Type: Call
• Strike Price: $50
• Expiration Date: 2026-08-21
• Key Stats: IV 78.36%, Leverage Ratio 15.62%, Delta 0.54, Theta -0.18, Gamma 0.05, Turnover 20,776

• IV 78.36%: High implied volatility indicates significant expected price movement.
• Leverage Ratio 15.62%: Offers substantial leverage for capital efficiency.
• Delta 0.54: Moderate delta provides balanced sensitivity to stock price changes.
• Theta -0.18: High time decay requires timely execution to mitigate losses.
• Gamma 0.05: High gamma amplifies gains as the stock moves in the desired direction.
• Turnover 20,776: High liquidity ensures easy entry and exit.

This contract stands out due to its high liquidity and optimal delta for capturing the current momentum. The high gamma allows traders to benefit significantly from rapid price increases, making it ideal for short-term speculative plays.

Contract 2: TXG20260918C50
• Code: TXG20260918C50
• Type: Call
• Strike Price: $50
• Expiration Date: 2026-09-18
• Key Stats: IV 74.49%, Leverage Ratio 9.61%, Delta 0.56, Theta -0.08, Gamma 0.03, Turnover 5,100

• IV 74.49%: High implied volatility reflects market uncertainty and potential for large moves.
• Leverage Ratio 9.61%: Provides moderate leverage with less risk than near-term options.
• Delta 0.56: Slightly higher delta offers better price sensitivity than the near-term call.
• Theta -0.08: Lower time decay compared to near-term options allows for holding longer.
• Gamma 0.03: Moderate gamma provides some acceleration benefits without extreme risk.
• Turnover 5,100: Adequate liquidity for standard trading volumes.

This contract offers a slightly more conservative approach with lower theta decay, allowing traders to hold the position longer while still benefiting from the stock's upward trend. The lower time decay makes it suitable for traders who anticipate a gradual rise rather than an immediate spike.

Options Payoff Calculation Primer: For this payoff estimation, we assume a 5% upside scenario from current price (49.96) where for Call Option Payoff = max(0, ST - K) where ST is projected price and K is strike price and Put Option Payoff = max(0, K - ST) where ST is projected price and K is strike price. This projection helps evaluate option contracts' potential returns under a continued bullish move scenario.

Aggressive bulls may consider TXG20260821C50 for immediate upside potential, while those seeking a slightly longer horizon with reduced time decay risk should look at TXG20260918C50.

Maintain Bullish Stance with Caution at 52-Week Highs
The 9.56% surge signals strong buyer interest, but traders should exercise caution as the stock tests its 52-week high of $50.47. A sustained hold above $47.23 will confirm the breakout, while a drop below could trigger a pullback to the 30-day moving average. Investors should monitor volume and options flow for signs of continued momentum. Meanwhile, sector leader Illumina (ILMN) is down 2.21%, highlighting the idiosyncratic nature of TXG's rally. Watch for a breakout above $50.50 to confirm further upside potential or a rejection at this level for a potential short-term correction.